The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

[1] Akhavan Rezayat A(2018)Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis SAGE Open Med 6 2050312117745223-19

[2] Dadgar Moghadam M(2002)Treatment of nonalcoholic fatty liver disease Ann Hepatol 1 12-1405

[3] Ghasemi Nour M(2014)Adiponectin polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis J Gastroenterol Hepatol 29 1396-5176

[4] Angulo P(2013)Epidemiology and natural history of patients with NAFLD Curr Pharm Des 19 5169-166

[5] Wang J(2012)Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis J Hepatol 57 157-384

[6] Guo XF(2010)A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 372-357

[7] Yu SJ(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-1848

[8] Bhala N(2016)Perspectives on treatment for nonalcoholic steatohepatitis Gastroenterology 150 1835-378

[9] Younes R(2015)Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis Gastroenterology 149 367-1979

[10] Bugianesi E(2011)A two-year randomized trial of obesity treatment in primary care practice N Engl J Med 365 1969-98

[1] Akhavan Rezayat A(2018)Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis SAGE Open Med 6 2050312117745223-19

[2] Dadgar Moghadam M(2002)Treatment of nonalcoholic fatty liver disease Ann Hepatol 1 12-1405

[3] Ghasemi Nour M(2014)Adiponectin polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis J Gastroenterol Hepatol 29 1396-5176

[4] Angulo P(2013)Epidemiology and natural history of patients with NAFLD Curr Pharm Des 19 5169-166

[5] Wang J(2012)Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis J Hepatol 57 157-384

[6] Guo XF(2010)A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 372-357

[7] Yu SJ(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-1848

[8] Bhala N(2016)Perspectives on treatment for nonalcoholic steatohepatitis Gastroenterology 150 1835-378

[9] Younes R(2015)Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis Gastroenterology 149 367-1979

[10] Bugianesi E(2011)A two-year randomized trial of obesity treatment in primary care practice N Engl J Med 365 1969-98